PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3049% below fair value
$23.78+0.24 (+1.02%)
Close on Nov 17, 2026Market cap $1.36BP/E –Yield –
PROCEPT BioRobotics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
PROCEPT BioRobotics's operating income for the twelve months ending Jun 30, 2026 was -$114.23M. For fiscal 2025 it was -$103.86M. The highest annual figure on record is -$47.80M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$103.86M | – |
| FY2024 | Dec 31, 2024 | -$96.61M | – |
| FY2023 | Dec 31, 2023 | -$109.17M | – |
| FY2022 | Dec 31, 2022 | -$80.72M | – |
| FY2021 | Dec 31, 2021 | -$54.16M | – |
| FY2020 | Dec 31, 2020 | -$47.80M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$27.39M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$31.04M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.19M | – |
| Q2 FY2025 | Jun 30, 2025 | -$22.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.44M | – |
| Q4 FY2024 | Dec 31, 2024 | -$19.71M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.43M | – |
| Q2 FY2024 | Jun 30, 2024 | -$26.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$27.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.56M | – |
| Q3 FY2023 | Sep 30, 2023 | -$25.61M | – |
| Q2 FY2023 | Jun 30, 2023 | -$25.63M | – |
| Q1 FY2023 | Mar 31, 2023 | -$28.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$25.04M | – |
| Q3 FY2022 | Sep 30, 2022 | -$22.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.83M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.19M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.34M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.21M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.98M | – |
See a number that looks wrong?